Cytocell launches Chromosome Multiprobe system:
This article was originally published in Clinica
Executive Summary
Cytocell (UK) has introduced the Chromoprobe Multiprobe system, a disposable kit which uses chromosome paints to detect complex abnormalities on all 24 chromosomes simultaneously on a single slide. Since the chromosome probes are directly labelled, lengthy post-hybridisation amplification steps are often not necessary, Cytocell says. The company has applied for patent coverage for the technology used in the kit. It is also developing another Multiprobe kit for chromosome enumeration in leukaemia cytogenetics. The Multiprobe system was originally developed by the Department of Biochemistry at Oxford University and Oxford's Churchill Hospital.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.